Overview

Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This observational study tests the hypothesis that endogenous aldosterone impairs insulin secretion and insulin sensitivity in subjects with primary aldosteronism.
Details
Lead Sponsor:
Vanderbilt University
Collaborators:
Brigham and Women's Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Treatments:
Eplerenone
Mineralocorticoid Receptor Antagonists
Mineralocorticoids
Spironolactone